Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Taylor

Showing results (181-190 of 246) with videos related to

Pageof 25
Sort By:
The Journal of Rheumatology|October 5, 2010
Quantitative power Doppler ultrasonography is a sensitive measure of metacarpophalangeal joint synovial vascularity in rheumatoid arthritis and declines significantly following a 2-week course of oral low-dose corticosteroidsMaggie J Larché, Matthew Seymour, Adrian Lim, et al.
Plos One|August 14, 2013
T1-weighted sodium MRI of the articulator cartilage in osteoarthritis: a cross sectional and longitudinal studyRexford D Newbould, Sam R Miller, Neil Upadhyay, et al.
The Lancet. Rheumatology|January 31, 2024
Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trialRoy Fleischmann, Alan Friedman, Edit Drescher, et al.
Lupus|November 1, 2021
Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement studyLine Uhrenholt, Simone Høstgaard, Julie F Pedersen, et al.
Rheumatology and Therapy|September 8, 2022
Identifying and Quantifying the Role of Inflammation in Pain Reduction for Patients With Psoriatic Arthritis Treated With Tofacitinib: A Mediation AnalysisKurt de Vlam, Philip J Mease, Andrew G Bushmakin, et al.
Seminars in Arthritis and Rheumatism|November 7, 2018
Added value of combining methotrexate with a biological agent compared to biological monotherapy in rheumatoid arthritis patients: A systematic review and meta-analysis of randomised trialsSimon Tarp, Tanja S Jørgensen, Daniel E Furst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2018
Translocator Protein as an Imaging Marker of Macrophage and Stromal Activation in Rheumatoid Arthritis PannusNehal Narayan, David R Owen, Harpreet Mandhair, et al.
RMD Open|March 13, 2024
Impact of filgotinib on pain control in the phase 3 FINCH studiesPeter C Taylor, Arthur Kavanaugh, Peter Nash, et al.
Rheumatology (Oxford, England)|April 30, 2009
Contemporary treatment principles for early rheumatoid arthritis: a consensus statementPatrick D W Kiely, Andrew K Brown, Christopher J Edwards, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2016
Effects of Baricitinib on Lipid, Apolipoprotein, and Lipoprotein Particle Profiles in a Phase IIb Study of Patients With Active Rheumatoid ArthritisJoel M Kremer, Mark C Genovese, Edward Keystone, et al.
Pageof 25

Showing results (181-190 of 246) with videos related to

Sort By:
Pageof 25
The Journal of Rheumatology|October 5, 2010
Quantitative power Doppler ultrasonography is a sensitive measure of metacarpophalangeal joint synovial vascularity in rheumatoid arthritis and declines significantly following a 2-week course of oral low-dose corticosteroidsMaggie J Larché, Matthew Seymour, Adrian Lim, et al.
Plos One|August 14, 2013
T1-weighted sodium MRI of the articulator cartilage in osteoarthritis: a cross sectional and longitudinal studyRexford D Newbould, Sam R Miller, Neil Upadhyay, et al.
The Lancet. Rheumatology|January 31, 2024
Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trialRoy Fleischmann, Alan Friedman, Edit Drescher, et al.
Lupus|November 1, 2021
Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement studyLine Uhrenholt, Simone Høstgaard, Julie F Pedersen, et al.
Rheumatology and Therapy|September 8, 2022
Identifying and Quantifying the Role of Inflammation in Pain Reduction for Patients With Psoriatic Arthritis Treated With Tofacitinib: A Mediation AnalysisKurt de Vlam, Philip J Mease, Andrew G Bushmakin, et al.
Seminars in Arthritis and Rheumatism|November 7, 2018
Added value of combining methotrexate with a biological agent compared to biological monotherapy in rheumatoid arthritis patients: A systematic review and meta-analysis of randomised trialsSimon Tarp, Tanja S Jørgensen, Daniel E Furst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2018
Translocator Protein as an Imaging Marker of Macrophage and Stromal Activation in Rheumatoid Arthritis PannusNehal Narayan, David R Owen, Harpreet Mandhair, et al.
RMD Open|March 13, 2024
Impact of filgotinib on pain control in the phase 3 FINCH studiesPeter C Taylor, Arthur Kavanaugh, Peter Nash, et al.
Rheumatology (Oxford, England)|April 30, 2009
Contemporary treatment principles for early rheumatoid arthritis: a consensus statementPatrick D W Kiely, Andrew K Brown, Christopher J Edwards, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2016
Effects of Baricitinib on Lipid, Apolipoprotein, and Lipoprotein Particle Profiles in a Phase IIb Study of Patients With Active Rheumatoid ArthritisJoel M Kremer, Mark C Genovese, Edward Keystone, et al.
Pageof 25